A detailed history of Evoke Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Evoke Wealth, LLC holds 8,146 shares of AMGN stock, worth $2.15 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,146
Holding current value
$2.15 Million
% of portfolio
0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $2.52 Million - $2.75 Million
8,146 New
8,146 $2.62 Billion
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $50,547 - $61,017
-188 Reduced 2.3%
7,997 $2.27 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $71,851 - $81,057
281 Added 3.56%
8,185 $2.36 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $35,421 - $43,976
162 Added 2.09%
7,904 $2.12 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $41,568 - $49,153
-194 Reduced 2.44%
7,742 $1.72 Million
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $80,607 - $98,246
-357 Reduced 4.3%
7,936 $1.92 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $54,967 - $69,842
240 Added 2.98%
8,293 $2.18 Million
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $64,195 - $72,400
286 Added 3.68%
8,053 $1.82 Million
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $47,756 - $53,145
207 Added 2.74%
7,767 $1.89 Million
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $323,861 - $358,275
-1,477 Reduced 16.34%
7,560 $1.83 Million
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $39,974 - $45,747
-201 Reduced 2.18%
9,037 $2.03 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $57,100 - $66,900
269 Added 3.0%
9,238 $1.96 Million
Q2 2021

Aug 05, 2021

BUY
$233.58 - $259.14 $5,839 - $6,478
25 Added 0.28%
8,969 $2.19 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $1.55 Million - $1.81 Million
6,982 Added 355.86%
8,944 $2.23 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $11,684 - $13,914
-54 Reduced 2.68%
1,962 $451,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $18,772 - $20,876
80 Added 4.13%
2,016 $513,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $25,913 - $31,798
-131 Reduced 6.34%
1,936 $457,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $137,226 - $182,000
-753 Reduced 26.7%
2,067 $419 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $37,842 - $48,640
200 Added 7.63%
2,820 $680 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $456,168 - $546,584
2,620 New
2,620 $507 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.